Literature DB >> 4032403

Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis.

M D Smith, R A Gibson, P M Brooks.   

Abstract

Intestinal permeability was measured using a low molecular weight polyethylene glycol as a permeability marker in patients with osteoarthritis, ankylosing spondylitis (AS) and rheumatoid arthritis (RA). Patients with AS showed a significant increase in bowel permeability when compared to controls. Intestinal permeability was also increased in patients with active RA but was less than the control group in RA patients who did not have active joint disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4032403

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  24 in total

Review 1.  Small intestinal mucosal protection mechanisms and their importance in rheumatology.

Authors:  S O'Mahony; A Ferguson
Journal:  Ann Rheum Dis       Date:  1991-05       Impact factor: 19.103

Review 2.  The microbiome, HLA, and the pathogenesis of uveitis.

Authors:  James T Rosenbaum; Phoebe Lin; Mark Asquith
Journal:  Jpn J Ophthalmol       Date:  2015-09-14       Impact factor: 2.447

Review 3.  Clostridium difficile toxin-induced reactive arthritis in a patient with chronic Reiter's syndrome.

Authors:  A Cope; J Anderson; E Wilkins
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

4.  Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?

Authors:  A J Morris; C W Howden; C Robertson; A Duncan; H Torley; R D Sturrock; R I Russell
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

Review 5.  HLA-B27 and bacteria.

Authors:  J Uksila; P Toivanen
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

6.  Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis.

Authors:  O Mäki-Ikola; R Hällgren; L Kanerud; N Feltelius; L Knutsson; K Granfors
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

7.  Immune complexes in ankylosing spondylitis.

Authors:  I L MacLean; J R Archer; M I Cawley; B L Kidd; B P O'Hara; F S Pegley; P W Thompson
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

8.  Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.

Authors:  K M Sanders; A Hertzman; M R Escobar; B H Littman
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

9.  Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease.

Authors:  R Cooper; S M Fraser; R D Sturrock; C G Gemmell
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-21

10.  Effects of prostaglandin E2 on disease activity, gastric secretion and intestinal permeability, and morphology in patients with rheumatoid arthritis.

Authors:  A E Henriksson; C Tagesson; A Uribe; K Uvnäs-Moberg; C E Nord; R Gullberg; C Johansson
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.